Tracey Schefter, University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz Medical Campus

Tracey Schefter, University of Colorado Cancer Center

Caption

University of Colorado Cancer Center investigator Tracey Schefter, M.D., and colleagues report promising results for the addition of bevacizumab (Avastin) to standard of care in locally advanced cervical cancer.

Credit

UC Denver

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.